跳至主要内容
临床试验/NCT05652816
NCT05652816招募中早期 1 期

Substitute Graft for Burns Using Biological Graft Seeded With Autologous Keratinocyte Co-cultured With Stem Cells

Indonesia University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年9月6日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
招募中
入组人数
20
试验地点
2
主要终点
Burn thermography

研究概览

简要总结

The goal of this clinical trial is to test whether artificial skin graft can substitute autologous skin graft in current burn treatment. The main question it aims to answer is:

• Can artificial skin graft result in better wound healing compared to the current burn treatment; autologous skin graft?

You will:

  • Undergo debridement surgery
  • Receive artificial skin graft as an alternative to autologous skin graft
  • Undergo biopsy procedure of burn area

If there is a comparison group: Researchers will compare autologous skin graft group to see the wound healing process

详细描述

Burn caused by working accidents occurs mostly in the male population of productive age (68.68%). Up to this date, the only treatment for grade 2B-3 burns patients in Indonesia is skin transplantation taken from their own body (autologous skin graft). This treatment has several drawbacks in which repeated surgery is sometimes necessary, the source of skin in patients with wide area of burn is limited, and patients that are in the elder age and have comorbidities have high mortality risk.

In order to find an alternative for autologous skin graft therapy, a combination of tissue engineering and stem cell therapy is used to invent an artificial skin graft. The present study attempts to evaluate the efficacy of artificial skin graft seeded with autologous keratinocyte and stem cells towards wound healing in burn patients. The artificial graft used in this study is amnion bilayer; a graft that was decellularized to remove donor's cells and then layered to form into 3-D.

To evaluate the efficacy, biopsies are taken from the burn area of patients to evaluate the histoarchitecture of patients' tissue by histological staining (H&E and Movat's pentachrome, IHC collagen I, collagen III, vWF, and alpha-SMA) and measure the relative gene expression by qPCR. For clinical data, burn area calculation using Rule of 9 method and thermography measurement using FLIRONE. Furthermore, systemic evaluation of patients are done by monitoring the procalcitonin, lactate, mean arterial pressure, gradation of wound, and sensory of burn area. The evaluation and measurement mentioned above are then compared to patients treated with the current available therapy; autologous skin graft. The artificial skin graft is hoped to result in equal, if not better, wound healing in burn patients compared to autologous skin graft. The investigators hope that artificial skin graft can be an option, other than autologous skin graft, in treating burn patients in the future.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 - 55
  • Area of burn <50%
  • Acute phase burn (<120 hrs)
  • Have not undergo any surgery for burn treatment

排除标准

  • Immunocompromised
  • Have comorbidities

结局指标

主要结局

Burn thermography

时间窗: Day 14 after surgery

Thermography evaluation using FLIRONE

Burn thickness

时间窗: Day 14 after surgery

Thickness of burn evaluation using Rule of 9

Systemic clinical evaluation

时间窗: Day 14 after surgery

Mean arterial pressure measurement

Histoarchitecture evaluation

时间窗: Day 14 after surgery

Haematoxylin \& Eosin staining

Immunohistochemistry

时间窗: Day 14 after surgery

collagen-1 labelling

Wound healing relative gene expression

时间窗: Day 14 after surgery

TGFB1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

dr. Aditya Wardhana

Head of Burns Unit, Cipto Mangunkusumo National Hospital

Indonesia University

研究点 (2)

Loading locations...

相似试验